It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The possibility to analyse the tumour genetic material shed in the blood is undoubtedly one of the main achievements of translational research in the latest years. In the modern clinical management of advanced non-small cell lung cancer, molecular characterisation plays an essential role. In parallel, immunotherapy is widely employed, but reliable predictive markers are not available yet. Liquid biopsy has the potential to face the two issues and to increase its role in advanced NSCLC in the next future. The aim of this review is to summarise the main clinical applications of liquid biopsy in advanced non-small cell lung cancer, underlining both its potential and limitations from a clinically driven perspective.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Istituto Oncologico Veneto IOV—IRCCS, Medical Oncology 2, Padova, Italy (GRID:grid.419546.b) (ISNI:0000 0004 1808 1697)
2 Istituto Oncologico Veneto IOV—IRCCS, Medical Oncology 2, Padova, Italy (GRID:grid.419546.b) (ISNI:0000 0004 1808 1697); University of Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
3 AULSS 3 Serenissima, Medical Oncology Department, Mestre-Venezia, Italy (GRID:grid.5608.b)
4 Istituto Oncologico Veneto IOV—IRCCS, Basic and Translational Oncology, Padova, Italy (GRID:grid.419546.b) (ISNI:0000 0004 1808 1697)
5 San Bortolo General Hospital, Medical Oncology Department, Vicenza, Italy (GRID:grid.411474.3) (ISNI:0000 0004 1760 2630)
6 University of Padova, Department of Surgery, Oncology and Gastroenterology, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470); Istituto Oncologico Veneto IOV—IRCCS, Basic and Translational Oncology, Padova, Italy (GRID:grid.419546.b) (ISNI:0000 0004 1808 1697)